undamentalytics Newsletter
Sign in

Biocardia, Inc. revenue

Biocardia, Inc.'s revenue was $0 in fiscal 2025, down 100.0% on the year before.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Revenue0129045764796257101451,0151,352477580
Growth on the year before——+>999%−36.3%−16.8%+30.5%+13.6%−79.6%+600.0%+33.2%−64.7%−87.8%−100.0%
Gross profit012—−170−2111083521411,015————
Gross margin—100.0%—−29.5%−44.1%17.3%49.6%97.2%100.0%————

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Biocardia, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biocardia, Inc.